Instruction for use: Depo-ProveraI want this, give me price
Active substance Medroxyprogesterone
ATX code G03AC06Medroxyprogesterone
Estrogens, gestagens; Their homologues and antagonists
Antineoplastic hormonal agents and hormone antagonists
Composition and form of release
Suspension for injection 1 ml
Medroxyprogesterone acetate 150 mg
Auxiliary substances: polyethylene glycol 3350; Polysorbate 80; sodium chloride; Methylparaben; Propylparaben; water for injections
In a disposable syringe and 1 ml vials or in bottles of 3.3 and 6.7 ml; In a pack of cardboard 1 syringe or 1 bottle.
The pharmacological action is gestagenic, antitumoral.
Dosing and Administration
In / m (intramuscularly). Endometrial cancer and kidney cancer: 400-1000 mg per week for several weeks or months, after achieving stabilization, they switch to maintenance therapy - 400 mg per month.
Breast cancer: 500 mg / day for 28 days, then go on a maintenance dose of 500 mg 2 times a week until signs of disease progression.
Immediately before use, the vial should be shaken well so that the injected preparation becomes a homogeneous suspension.
At a temperature of 20-25 ° C.
Keep out of the reach of children.
Do not use after the expiration date stated on the package